Oxford immunologist to discuss the potential of HIV vaccines
Lectures scheduled Feb. 6 at noon in Davis and 5 p.m. in Sacramento
Professor Sir Andrew McMichael of the Weatherall Institute of Molecular Medicine at the University of Oxford in the United Kingdom will be the UC Davis School of Medicine’s 2013
There are two opportunities to hear McMichael’s address, which is titled “T-cell immune responses against HIV-1: Can they be harnessed by vaccines?” He will speak on Wednesday, Feb. 6, at noon in the auditorium of the Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, at UC Davis, and at 5 p.m. in the Matsui Lecture Hall of the Education Building, 4610 X St., in Sacramento.
Both lectures are free and open to the public. To reserve a seat, e-mail specialevents or call 916-734-9101.
Widely recognized as an expert in the molecular events involved in viral infection, McMichael is currently testing a series of T-cell boosting vaccines to determine if they can replace traditional drug treatments in preventing or controlling human immunodeficiency virus (HIV). He was knighted for his service to medical science in the United Kingdom, where he is also a fellow of both the Royal Society and the Academy of Medical Sciences.
“Sir McMichael has a unique understanding of HIV signaling pathways and how immune system responses can potentially be enhanced to overcome them,” said Eric Gershwin, chief of the UC Davis Division of Rheumatology, Allergy and Clinical Immunology. “His research is transforming how we think about vaccines and aggressive viruses, and we are thrilled he is able to share his recent outcomes with us.”
The Nelson Lectureship was established to honor the legacy of Woodland, Calif., pioneers Camillus and Elizabeth Nelson and to bring thought-provoking speakers in medicine and science to the region.